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What's new? 
 Most studies on the impact of multifaceted, structured, primary care programmes on 
the quality of diabetes care have a short follow-up time; studies demonstrating long-
term sustainability are lacking.  
 We found significant improvements in quality of care (care processes delivered) 
among practices enrolled in a primary care programme over a 16-year period. 
 Lifestyle processes were less well recorded, and there were declines in foot 
assessment and attendance at annual review, and participants continued to have poor 
risk factor control. 
 Programmes may be limited when operating within the constraints of primary care 
and the wider service context. 
 
Abstract  
Aim  To examine the quality of care delivered by a structured primary care-led programme 
for people with Type 2 diabetes mellitus in 1999–2016. 
 
Methods The Midland Diabetes Structured Care Programme provides structured primary 
care-led management. Trends over time in care processes were examined (using a chi-
squared trend test and age- and gender-adjusted logistic regression). Screening and annual 
review attendance were reviewed. A composite of eight National Institute for Health and 
Care Excellence-recommended processes was used as a quality indicator.  Participants who 
were referred to diabetes nurse specialists were compared with those not referred (Student’s 
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outcome targets [HbA1c ≤58 mmol/mol (7.5%), blood pressure ≤140/80 mmHg, cholesterol 
<5.0 mmol/l] were calculated. 
 
Results Data were available for people with diabetes aged ≥18 years: 1998/1999 (n=336); 
2003 (n=843); 2008 (n=988); and 2016 (n=1029). Recording of some processes improved 
significantly over time (HbA1c, cholesterol, blood pressure, creatinine), and in 2016 exceeded 
97%. Foot assessment and annual review attendance declined. In 2016, only 29% of 
participants had all eight National Institute for Health and Care Excellence processes 
recorded. A higher proportion of people with diabetes who were referred to a diabetes nurse 
specialist had poor glycaemic control compared with those not referred. The proportions 
meeting blood pressure and lipid targets increased over time.  
 
Conclusions Structured primary care led to improvements in the quality of care over time. 
Poorer recording of some processes, a decline in annual review attendance, and participants 
remaining at high risk suggest limits to what structured care alone can achieve. Engagement 
in continuous quality improvement to target other factors, including attendance and self-
management, may deliver further improvements.  
 
Introduction 
Diabetes mellitus is a complex chronic condition requiring structured management, including 
a focus on treatment goals for blood pressure,  glucose control and lipids, regular review and 
recall, screening for complications, and input from a multidisciplinary professional team [1]. 
Primary care, as a first point of contact and source of continuous, comprehensive and 
coordinated care, is often seen as a starting point for the delivery and organization of diabetes 
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care if well supported and organized [2]. Efforts to optimize care across different health 
systems have led disease management programmes to better organize management in primary 
care and improve coordination between the community, outpatient/ambulatory and inpatient 
settings [3–5].  
 
Disease management programmes in primary care incorporate different components: 
multidisciplinary cooperation; registration systems; audit and feedback; clinician reminders; 
patient and professional education; and/or the establishment of a specific communication 
system and ongoing collaboration between specialities and primary care (shared care). 
Structured approaches to diabetes care, combining some or all of these elements, demonstrate 
improvements in glycaemic control and cardiovascular risk factors [4,6], although the 
evidence for the effectiveness of shared care is less certain [7,8]. Specific components 
delivering significant improvements in clinical outcomes [6,8,9] and care processes [6], 
include access to a multidisciplinary team [8], case management [8], partial replacement of 
physicians by nurses [9], self-management promotion [8], and interventions to prompt recall 
and review of patients, including electronic registries, reminders and tracking systems [6]. 
Interventions operating at all levels of the health system (system, provider and patient), 
however, have demonstrated a greater effect on glycaemic control than interventions 
targeting a single level [8].  
 
Despite growing evidence regarding ways to improve the quality of diabetes care, some 
uncertainties remain, including whether the effects achieved by evaluative quality 
improvement studies can be replicated in ‘real-life’ practice. Despite international consensus 
on optimal diabetes management, a gap persists between recommendations and actual 
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workforce shortages [2,11], demonstrating the long-term sustainability of structured primary 
care management is a challenge. Internationally, high-quality service evaluations to address 
this evidence gap are lacking [11]. Most studies examining diabetes management in primary 
care have a relatively short follow-up [4,6,7], cannot provide an insight into the sustainability 
of these programmes over time, and may not be able to demonstrate effectiveness [7]. Few 
studies evaluate enhanced models of primary care management over a longer period, of 10 
years or more [12–14].    
 
In Ireland [15], as elsewhere in Europe [5], national policy in recent years has focused on 
moving from hospital-led management to delivering care in the community. Diabetes care is 
historically unstructured, but formal primary care initiatives have been developed across the 
country to improve the quality of care and service delivery at a local level. The longest 
running is the HSE Midland Diabetes Structured Care Programme (Midland Programme), 
established in 1997/1998. We aimed to examine the quality of care delivered by the Midland 
Programme over a long follow-up period (1999–2016) through a series of cross-sections. We 
reviewed the delivery of the programme by examining trends in the processes of care 
performed for people with Type 2 diabetes mellitus and benchmarked the programme against 




In Ireland, the national prevalence of doctor-diagnosed diabetes among adults aged ≥18 years 
is 5.2%, an increase from 2.2% in 1998 [18]. Over one-third of adults (37%) are overweight 
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Midland Diabetes Structured Care Programme 
The Midland Programme, based in four counties in Ireland (Longford, Westmeath, Laois and 
Offaly), includes several evidence-based intervention components: adoption of clinical 
guidelines; patient register and recall and protected time for review (three 30-min visits per 
year); organization and coordination of care by practice nurses; structured multidisciplinary 
support; and professional and patient education [8,9]. Practices are remunerated for patients’ 
visits through an existing chronic disease programme, Heartwatch, or reimbursed for practice 
nurse time. Practices receive clinical (diabetes nurse specialists, podiatry/chiropody, dietetic), 
educational, and administrative support, which has changed since the programme was first 
established; for example, there has been a loss of dietetic support (Fig. 1).   
 
Data collection 
Diabetes nurse specialists extracted data from practice records on people with Type 1 and 
Type 2 diabetes (aged ≥18 years) enrolled at four time points: 1998/1999; 2003; 2008; and 
2016. A census sample was selected in 1998/1999 and 2003, and a random sample in 2008 
and 2016. In 2008, participants were sampled by sorting alphabetically first by name, and 
selecting every third person. In 2016, all participants who were still alive and were part of the 
census sample in 1998/1999 were selected. After ordering randomly, every third person was 
sampled from these participants. The remainder of the participants in 2016 were sampled by 
sorting alphabetically first by name, then sampling every third person. This approach was 
taken to approximate a random sample overall in 2016. Sample size was calculated based on 
precision of HbA1c estimates.  In 2003, the mean HbA1c for the total sample was 60 
mmol/mol (7.6%) and the 95% CI was ± 1 mmol/mol (0.11%), which equates to ~1.5%; 
therefore, a confidence level of 95% and CI of 2% was chosen to calculate the sample size for 
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was 1168.  Based on the total population of participants in 2016 of 3797, the sample size was 
1471.  Only data on participants with Type 2 diabetes are reported here. 
 
Data sources included clinical notes (electronic and paper), outpatient appointments letters 
and referrals to chiropody/podiatry, retinopathy and dietetics. Data were collected on 
demographics: age, gender and general medical services status (a means-tested method of 
public health insurance; general medical services cardholders have free access to general 
practitioner services and medications) [20]. Data were also collected on diabetes type, 
duration, annual review attendance, use of diabetes-related services (retinopathy screening, 
specialist eye services (any service in community or hospital, private or public), diabetes 
nurse specialist or podiatrist/chiropodist), prescription of diabetes medications (oral 
hypoglycaemic agents, insulin, injectables) and other medications (statins, angiotensin-
converting enzyme  inhibiters, aspirin). Data were collected on care processes carried out in 
the previous 12 months: foot assessment carried out by any healthcare professional (i.e. 
general practitioner, practice nurse, diabetes nurse specialist, consultant, podiatrist), 
measurement of glycated haemoglobin (HbA1c), cholesterol, blood pressure, creatinine, 
albumin creatinine ratio, BMI, smoking status) and intermediate clinical outcomes (HbA1c, 
cholesterol, triglycerides, blood pressure, creatinine). Smoking status (yes/no) in the past 12 
months was determined on the basis of participants’ response to a question about whether 
they smoke now.  Data on complications were also collected: retinopathy, macrovascular 
[heart attack (myocardial infarction), heart failure (congestive cardiac failure), stroke 
(cerebrovascular accident), and mini stroke (transient ischemic attack)], peripheral 
neuropathy, autonomic neuropathy, foot risk category, and ulcer. Both eyes are checked 
during assessments and people were classified as having retinopathy if it was recorded in at 
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was recorded on the basis of the highest risk in either foot. Ulcer was recorded as 'yes' if the 
person had an ulcer in at least one foot. 
 
Analysis 
Practice addresses were mapped to Electoral Divisions and assigned a deprivation score and 
decile using the 2011 National Deprivation Index for Health and Health Services Research 
developed by the Small Area Health Research Unit [21]. Data were represented as means ± 
SD or median (interquartile range; continuous data) or numbers and proportions (categorical 
data). Quality of care was defined using a  composite of eight care processes recommended 
by the National Institute for Health and Care Excellence (NICE): HbA1c, blood pressure, 
cholesterol, smoking status, BMI, creatinine, albumin creatinine ratio and foot 
examination[22], while recording of triglycerides was reported, this process was excluded 
from the composite. Trends over time in the proportion with processes recorded were 
examined using the chi-squared test for trend, and logistic regression models adjusted for age 
and gender.  Trends in recording were examined for selected processes collected across all 4 
years (HbA1c, blood pressure, cholesterol, smoking status, BMI, creatinine) across practices.  
Differences in the proportion with processes recorded between participants aged <75 years 
and ≥75 years were examined using Pearson’s chi-squared test. The proportions attending 
annual review and diabetes-related services were reported at different time points. 
Differences in the demographic and clinical profile of participants referred and those not 
referred to a diabetes nurse specialist were tested using Student’s t-test or Wilcoxon–Mann–
Whitney test (continuous data), and Pearson’s chi-squared test (categorical data). Guidelines 
recommend people with complicated Type 2 diabetes mellitus  attend a diabetes nurse 
specialist [23]. People with complicated Type 2 diabetes are defined as those requiring 










This article is protected by copyright. All rights reserved. 
(not insulin), and those with complications or graded as having a high-risk foot [23]. 
Continuous outcome data were categorized according to international standards: blood 
pressure ≤140/80 mmHg, triglycerides <2.0 mmol/l, cholesterol 5.0 mmol/l and HbA1c ≤58 
mmol/mol (7.5%) [16,17, 24], and proportions of participants meeting clinical outcome 
targets were calculated.  All analysis was carried out in STATA v.12 for windows (StataCorp, 
College Station, TX, USA). 
  
Results 
Profile of the sample population 
Data on 336 people with Type 2 diabetes in 1998/1999 (10 practices), 843 in 2003 (20 
practices), 988 in 2008 (30 practices), and 1029 (30 practices) in 2016 were available for 
analysis. Overall <10% of data were missing, with some exceptions depending on time 
points: creatinine (1–31%), BMI (27–44%), smoking status (21–32%), podiatrist/chiropodist 
attendance (0–17%) and dietitian attendance (0–40%). Where missing data occur, the figures 
represent the recorded data. Over 85% of general practitioners were based in practices within 
the lowest deprivation deciles: 9 (n=14, 41%) or 10 (n=15, 44%). In 2016, the median 
(interquartile range) age of the cohort was 68 (60–76) years, most were men (n = 603, 59%) 
and most had a general medical services card (n = 823, 80%). The median duration of 
diabetes was 9 years. The profile of people with Type 2 diabetes was similar across time 















This article is protected by copyright. All rights reserved. 
Process measures 
In 2016, recording for most care processes was >97%. Recording improved significantly 
since 1998/1999, with change more evident between earlier time points (Fig. 2). Recording of 
BMI and smoking status remained consistently lower than other processes. Although there 
was a significant improvement between 1998/1999 and 2008 (BMI: 60% vs 73%; smoking 
status: 68% vs 77%) recording remained below 80% from 2008 to 2016. The proportion of 
participants with a foot assessment in the past 12 months declined from 2008 to 2016 (77% 
vs 53%). In 2016, only 29% (n = 296) of participants had all eight NICE-recommended 
processes recorded.   
 
Trends in recording were similar when stratified by age (<75 years and ≥75 years) with the 
exception of smoking status and blood pressure recording among participants <75 years 
(Table S1). At individual time points certain processes were consistently less well recorded 
(P< 0.05) among participants aged ≥75 years: 1999 (BMI: 64% vs 48%; triglycerides: 72% 
vs 51%), 2003 (BMI: 58% vs 48%; triglycerides: 93% vs 87%), 2008 (BMI: 75% vs 67%; 
triglycerides: 99% vs 96%; albumin creatinine ratio: 74% vs 67%), and 2016 (albumin 
creatinine ratio: 85% vs 75%) 
 
Consistent improvements in recording were seen across all practices for HbA1c, systolic 
blood pressure, cholesterol, triglycerides and creatinine. There was some variation in 
proportions recorded in 1999 among the 10 originally enrolled practices (HbA1c 0–100%; 
blood pressure 69–100%; cholesterol 0–100%; triglycerides 0–100%; creatinine 0–97%). 
BMI and smoking status recording did not improve consistently, with some practices 
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Attendance at annual review and diabetes-related services 
Annual diabetes review attendance increased between 1998/1999 (18%, n = 46/261) and 
2008 (91%, n = 895/980), but dropped in 2016 (77%, n = 788/1025). In 2016, clinical 
characteristics were recorded for most participants who attended and did not attend annual 
review (HbA1c: 100% vs 97%; blood pressure: 99% vs 93%; cholesterol: 100% vs 96%; 
creatinine: 100% vs 95%); however, there were differences in recording of foot assessment 
(57% vs 38%), BMI (79% vs 47%) and smoking status (86% vs 56%). A similar pattern was 
observed in 2008. In 2008, 58% of participants (n = 548/949) had seen a chiropodist or 
podiatrist in the past 12 months, which declined further by 2016 (51%, n = 439/863). In 2008, 
only 51% (n = 507/988) had attended specialist eye services, but in 2016, 80% (n = 
800/1006) of participants had attended either the national screening programme 
(RetinaScreen) or specialist eye services. The proportion who had seen a hospital or 
community dietitian dropped from 50% (n = 167/336) in 1998/1999 to 7.1% (n = 42/610) in 
2016, but recording quality also declined; 41% (n = 419/1029) were missing data in 2016 
compared with 0.3% (n = 1/336) in 1998/1999.   
 
Attendance at a diabetes nurse specialist increased between 2008 and 2016 (11% vs 15%). 
Participants who were referred had diabetes for longer and were younger than those who 
were not referred (Table 2). A greater proportion of people referred had poor glycaemic 
control [HbA1c >58 mmol/mol (7.5%); 50% vs 20%; P<0.001], were on oral hypoglycaemic 
agents or injectables (98% vs 81%; P<0.001), and had retinopathy (41% vs 30%; P<0.01); 
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Outcome targets  
Over time, the proportion meeting blood pressure and lipid targets increased, whereas the 
proportion with HbA1c ≤58 mmol/mol (7.5%) was similar (Table 1). Across time points, the 
proportion meeting all three outcome targets (HbA1c, blood pressure and cholesterol) ranged 
from 12% (1999) to 39% (2016). Those at high risk [HbA1c >58 mmol/mol (7.5%)] had 
diabetes for longer. The proportion on oral hypoglycaemic agents only was similar among 
high- and low-risk groups. A greater proportion at low risk were on oral hypoglycaemic 
agents or injectables (Table S3). 
 
Discussion 
We examined the quality of care delivered by a structured primary care management 
programme for people with Type 2 diabetes. We found significant improvements in process 
of care recording. These are consistent with changes in recording [3,6,13,14] reported by 
multifaceted international programmes with similar components: registration [6,13,14], 
practice guidelines [3,14], incentives [3], ongoing professional education [6,14], nurse case 
management [13], and structured multidisciplinary support [3]. Our findings suggest these 
changes can be sustained over time in a real-life setting; however, despite evidence of 
ongoing improvement, there may be limits to what structured programmes can achieve in the 
long term.  BMI and smoking status were consistently less well recorded, and performance of 
foot assessment and attendance at dietetic and annual review declined in the later years of the 
programme, and some participants remained at high risk. 
 
Unlike the Quality and Outcomes Framework in the UK, payment as part of the Midland 
Programme is not based on process recording.  Smoking status and BMI recording remained 
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based on Quality and Outcomes Framework data, and with other European countries [25].   
BMI and smoking status recording in the National Diabetes Audit, however, was also lower 
than recording of other processes. While incentivizing individual indicators can improve 
recording to a degree, poor documentation of certain processes may persist. Some may be 
given lower priority than other clinical measurements during review visits. BMI recording, 
for example, may only occur if a general practitioner or practice nurse recognizes the person 
with diabetes as overweight/obese, intends to offer management, or feels willing or able to 
engage in discussions about weight [26].  We found variation across practices in recording of 
BMI and smoking status, with some practices showing a decline in recording over time.  
With the exception of 2016, BMI was consistently less well recorded among older 
participants (aged ≥75 years). Foot assessments, also poorly recorded, have been more 
frequently performed among people with low income, poorer metabolic control, or 
complications, and less frequently by general practitioners compared with specialists [27]. 
Assessments may be time-consuming and unfeasible as part of regular review, or only 
prioritized when the general practitioner is aware of an increased risk of amputation. 
 
We found a significant, improving trend over time in recording of care processes; however, 
this was driven by more substantial improvements between earlier time points. There was 
minimal change between 2008 and 2016 once recording >97% had been achieved; however, a 
similar pattern was observed for BMI and smoking status, although these were less well 
recorded. This suggests that recording may plateau irrespective of whether near maximal 
recording has been achieved or not. A plateau was also observed in the UK 1 year after the 
introduction of the Quality and Outcomes Framework [28], suggesting limits to what can be 
achieved through incentives, regardless of the reimbursement method. This raises the 
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to deliver more sustained improvements [29]. This has implications for the new Diabetes 
Cycle of Care initiative introduced in Ireland in 2015, which remunerates general 
practitioners for care of people with stable Type 2 diabetes who hold a general medical 
services card. Practices are paid on the basis of registering eligible people with diabetes, 
delivering two review visits per year, recording and reporting on care processes (clinical 
characteristics, routine foot screening/referral, lifestyle review), not on the basis of meeting 
clinical targets. The initiative may improve the delivery of care processes, but only up to a 
point. Scotland has recently replaced the Quality and Outcomes Framework, establishing 
general practitioner quality clusters, small groups of practices which engage in local, peer-led 
quality improvement activities [29]. While they may see an initial decline in care processes, 
there is scope for improvement beyond what is achievable through payments.  
 
Although we did not track clinical outcomes in a fixed population, by reviewing outcomes in 
separate cross-sections, we gained some insight into the profile of people with diabetes 
receiving structured care.  In Ireland, 40% of older adults (≥55 years) are reported to have 
high blood pressure (systolic blood pressure ≥140 mmHg), and 41%  have cholesterol >5 
mmol/l [30].  Although recording of most processes in the Midland Programme was >97%, 
many participants were in high risk categories in terms of glycaemic control and their 
cardiovascular profile. Between 2003 and 2016, 26–40% had HbA1c >58 mmol/mol (7.5%), 
41–52% had blood pressure >140/80 mmHg, and 15–42% had cholesterol >5 mmol/l, 
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Recording clinical values is a quality measure in itself which may indicate the need to 
intensify treatment; however, achieving outcome targets requires appropriate action by 
professionals and people with diabetes. Emphasizing processes alone, as with the Cycle of 
Care, may not deliver improved outcomes. Motivation of the person with diabetes, adherence 
to treatment and the efficacy of self-management, influence risk factor management [10], but 
were not captured in the present study. We found the proportion of people with HbA1c ≤58 
mmol/mol (7.5%) was similar across time points, which could reflect the long disease 
duration among participants or the declining effect of oral hypoglycaemic agents [32]. While 
treatment goals provide a benchmark for quality, Lipska et al. [33] have recently questioned 
the use of ‘surrogate’ outcome targets, such as HbA1c, as quality indicators. They may not be 
appropriate for certain subgroups (e.g. the elderly or those with comorbidities) and should be 
individualized according to complication risk, preferences and control strategy. Greater 
emphasis has been placed on involving people with diabetes in the decision about their 
individual HbA1c target [16,17]. Future monitoring of the Midland Programme should 
consider incorporating this information; that is, recording whether a target has been agreed, 
documenting the agreed target, and using this as a basis for evaluating the quality of care. 
 
Although retinopathy screening attendance improved, in 2016, 20% had not attended 
specialist eye services or RetinaScreen, the new national screening and treatment programme 
introduced in 2013.  National guidelines recommend that people with complicated Type 2 
diabetes should attend a diabetes nurse specialist, including people requiring insulin, people 
with HbA1c >58 mmol/mol (7.5%) on two or more glucose-lowering agents (not insulin), or 
people with complications or graded as having a high-risk foot [23]. In line with this 
recommendation, we found participants with more complicated diabetes were referred to a 
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attend had a higher median HbA1c than attenders. Further work is necessary to understand 
barriers to attendance among these participants, ways to improve attendance, and facilitate 
risk management.  Although most participants attended for annual review, this declined 
between 2009 and 2016 (91% vs 77%). Transport, work and family commitments, and lack 
of motivation have been cited as reasons for non-attendance at annual review [34]; however, 
practice-level resource constraints could also account for this decline. An official annual 
review may not be performed at a single visit but instead components spread over several 
visits to lessen practice nurse workload. The increasing complexity of management may 
require longer reviews that cannot be incorporated into one visit [35]. Unlike clinical 
measurements, BMI, smoking status and foot assessment were less well recorded among 
those who did not attend annual review. These processes may not be a priority during regular 
visits, particularly for people with poor attendance.  
 
Ireland is moving towards the delivery of structured, integrated diabetes management in 
primary care, with the establishment of the National Clinical Programme for Diabetes, the 
resourcing of community-based ‘integrated’ diabetes nurse specialists to facilitate delivery of 
the new model of integrated care that manages people with diabetes according to their 
complexity, and the Cycle of Care (Fig. 1) [23]; however, as a multi-component programme 
with good specialist support, the Midland Programme provides an insight into the impact of 
providing structured care in the community that predates these national changes (Fig. 1). As 
enhanced access to community-based specialist resources does not form part of the Cycle of 
Care initiative, care may be moved to the community in areas with less access to a well-
resourced multidisciplinary team. Programmes such as the Midland Programme may also be 
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loss of resources, further indicating the importance of sustained resources to deliver care in 
the community.  
 
A strength of the present study is that it examines, over a long follow-up period, the impact of 
structured primary care-led service model, delivered in routine practice rather than as part of 
a quality improvement trial; however, participants were not the same at each time point 
(although some were represented at each). We also took different approaches to sampling at 
each time point. In 2008 and 2016, as the number enrolled in the programme exceeded 2000, 
it was not feasible to collect data manually on every participant, therefore, an appropriate 
random sample was taken. In 2016, as part of the larger sample taken at this time point, data 
were collected on all participants who had been enrolled in 1998/1999 and were still alive in 
2016.  This was done in order to facilitate a separate analysis which examines survival in the 
original cohort enrolled in the programme since its initiation. We can judge the overall 
delivery of the programme, but cannot infer the impact on individual participants since 
enrolment.  Although different individuals were represented across different time points, it is 
encouraging that participants enrolled in this structured care programme were meeting 
outcome targets; however, we lacked control practices to determine whether changes in 
clinical outcomes reflected overall improvements in medication (e.g. new oral hypoglycaemic 
agents) and management in the time period, or in the organization and delivery of the 
programme. Most participants enrolled were on lipid-lowering or blood pressure medication. 
The programme is multifaceted so we cannot prove that one component was more effective 
than others. Data were extracted from general practice records, and we depended on the 
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Our findings illustrate sustained improvements in the care delivered by practices in a 
multifaceted, primary-care led programme over time, suggesting this approach is feasible in 
real-life primary care; however, our findings also identify limits to what can be achieved by 
structured care programmes, particularly when operating within the resource constraints of 
primary care and the wider health service context. We need to better understand general 
practitioner management decisions, patient attendance, adherence and self-management, and 
whether these factors moderate the impact of these programmes. Programmes such as the 
Midland Programme should move beyond monitoring and engage in a continuous cycle of 
quality improvement to respond to the challenges of delivering optimal primary care-led 
diabetes care in everyday practice. 
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Supporting information 
 
Additional Supporting Information may be found in the online version of this article:  
 
Table S1. Processes recorded among participants aged <75 years and ≥75 years with Type 2 
diabetes 1999–2016. 
 
Table 2. BMI and smoking status recording among participants with Type 2 diabetes 1999–
2016 attending 10 general practices enrolled in programme since 1999. 
 
Table S3  Demographics, duration and diabetes control among participants with Type 2 
diabetes in 2016 (n = 1029). 
 
FIGURE 1 National reforms, resources available to the programme, and participating general 
practitioners and people with diabetes enrolled 1999–2016.  Information on numbers of 
resources (diabetes nurse specialists and podiatrists/chiropodists) were unavailable at time 
points between data collection. DNS, diabetes nurse specialist. 
 
FIGURE 2 Participants with nine care processes recorded 1999–2016.  *P < 0.05. Albumin: 
creatinine ratio was not recorded in 1999 and 2003; foot assessment was not recorded in 
1999. Proportions were analysed using a chi-squared test for trend and logistic regression 
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n = 336 
2003 
n = 843 
2008 
n = 988 
2016 
n = 1029 
Median (IQR) age, years 65 (56–74) 65 (56–73) 66 (59–74) 68 (60–76) 
Male, n (%) 168 (50) 438 (52) 562 (57) 603 (59) 










General medical services NA NA NA 823 (80) 
Mean (SD) BMI, kg/m
2
 29.3 (4.7) 30.6 (4.8) 30.6 (4.8) 31.2 (5.9) 
BMI <25 kg/m
2
, n (%) 33 (16) 42 (9) 94 (13) 81 (11) 
Smokers, n (%) 58 (25) 123 (20) 146 (19) 121 (15) 
Diabetes treatment, n (%)      
Diet only 60 (18) 187 (22) 131 (13) 173 (17) 
OHA only 262 (80) 532 (70) 685 (70) 643 (63) 
Insulin + OHA 0 (0) 39 (4.6) 131 (13) 140 (14) 
Insulin only 10 (3.0) 25 (3.0) 38 (3.9) 21 (2.0) 
Statins, n (%) NA NA 799 (81) 854 (83) 
ACE inhibitors, n (%) NA NA 734 (74) 680 (67) 
Aspirin, n (%) NA NA 740 (75) 611 (59) 











HbA1c  concentration, n (%)     
<48 mmol/mol  (6.5%) 104 (37) 229 (29) 351 (36) 364 (36) 
≤53 mmol/mol  (7.0%) 156 (55) 382 (48) 589 (61) 607 (59) 
≤58 mmol/mol  (7.5%) 191 (67) 481 (60) 720 (74) 770 (75) 
     
Mean (SD) systolic blood 
pressure, mmHg 
144.4 (19.9) 140.5 (18.7) 135.9 (16.3) 135.1 (16.0) 
Systolic blood pressure, n (%)      
<130/80 mmHg 25 (8.0) 96 (12) 212 (22) 212 (21) 
≤140/80 mmHg 112 (36) 405 (48) 560 (57) 597 (59) 
Mean (SD) cholesterol, mmol/l 5.3 (1.2) 4.9 (1.0) 4.1 (1.1) 4.1 (1.0) 
Cholesterol concentration, n (%)     
<4.5 mmol/l 60 (23) 268 (33) 647 (67) 711 (70) 
<5.0 mmol/l 102 (38) 450 (55) 785 (81) 846 (83) 
Mean (SD) triglycerides, mmol/l 2.4 (1.5) 2.1 (1.9) 1.8 (1.2) 1.7 (1.5) 
Triglycerides <2.0 mmol/l, n (%) 103 (46) 460 (60) 684 (71) 760 (75) 
Mean (SD) creatinine, µmol/l 86.5 (30.1) 84.8 (20.7) 87.8 (46.0) 86.5 (34.0) 
NA, not available (data on this variable were not collected at this time point); ACE, angiotensin-converting-enzyme; IQR, 
interquartile range; OHA, oral hypoglycaemic agent.  
*Based on available data: age: 1999 (336), 2003 (842), 2008 (987), 2016 (1,028). Diabetes duration: 2008 (848), 2016 
(1005). GMS: 2016 (1027).  BMI: 1999 (203), 2003 (470), 2008 (725), 2016 (736). Smoking status: 1999 (230), 2003 (629), 
2008 (759), 2016 (813). Diabetes treatment: 1999 (332), 2003 (843), 2008 (985), 2016 (1026). Statins: 2008 (987), 2016 
(1028). Aspirin: 2008 (986), 2016 (1027). ACE inhibitor: 2008 (984), 2016 (1017).  HbA1c: 1999 (284), 2003 (799), 2008 
(967), 2016 (1021). Blood pressure: 1999 (311), 2003 (836), 2008 (979), 2016 (1008). Cholesterol: 1999 (267), 2003 (815), 
2008 (973), 2016 (1018). Triglycerides: 1999 (226), 2003 (771), 2008 (968), 2016 (1012). Creatinine: 1999 (234), 2003 
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Table 2 Profile of participants who were referred to a diabetes nurse specialist* in 2016 
 Referred to diabetes nurse specialist 
 Yes 
n = 153 
 
No 
n = 866 
 
Yes, but did not attend 




, years 65 (56–71) 69 (61–76) 58 (53–63) 
Men, n (%) 88 (58) 511 
(59) 
4 (44) 
Median (IQR) diabetes duration
†
, years  10 (6–14) 9 (5–12) 9.5 (9–12) 
Mean (SD) BMI, kg/m
2
 32.1 (6.1) 31.0 (5.9) 32.6 (4.4) 
Smoker, n (%) 21 (18) 99 (14) 1 (13) 
Diabetes control
†
, n (%)    
Diet only 3 (2.0) 168 (19) 1 (11) 
OHA only 71 (47) 569 (66) 3 (33) 
Insulin only 5 (3.3) 15 (1.7) 1 (11) 
Insulin and OHA 57 (38) 81 (9.3) 2 (22) 
Injectables and OHA 16 (11) 31 (3.6) 2 (22) 
OHA or injectable
†‡
 149 (98) 696 (81) 8 (89) 















Mean (SD) systolic blood pressure, mmHg 133.7 (14.2) 135.4 (16.3) 127.2 (12.2) 
Complications, n (%)    
Retinopathy
†
 54 (41) 197 (30) 3 (50) 
Macrovascular 8 (5.2) 89 (10) 2 (22) 
Peripheral neuropathy 7 (4.6) 29 (3.4) 0 (0) 
Autonomic neuropathy 5 (3.3) 28 (3.2) 0 (0) 
High-risk foot
†
 2 (1.9) 14 (4.4) 1 (17) 
Ulcer  4 (2.7) 20 (2.3) 0 (0) 
IQR, interquartile range; OHA, oral hypoglycaemic agent.  
 *People with complicated Type 2 diabetes should attend a diabetes nurse specialist. This includes people 
requiring insulin, people with HbA1c >58 mmol/mol (7.5%) on two or more glucose-lowering agents (not 
insulin), and people with complications or graded as having a high-risk foot [23]. 
†
P < 0.05; difference in people attending and not attending diabetes nurse specialist visit were analysed using 
Student's t-test or Wilcoxon–Mann–Whitney test for continuous data and Pearson’s chi-squared for categorical 
data. 
‡
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